The dopamine D2 receptor is the main dopamine receptor expressed in the human normal pituitary gland. The aim of the current study was to evaluate dopamine D2 receptor expression in the corticotroph cell populations of the anterior lobe and pars intermedia, as well as posterior lobe of the human normal pituitary gland by immunohistochemistry. Human normal pituitary gland samples obtained from routine autopsies were used for the study. In all cases, histology together with immunostaining for adrenocorticotropic hormone, melanocyte-stimulating hormone, prolactin, and neurofilaments were performed and compared to the immunostaining for D2 receptor. D2 receptor was heterogeneously expressed in the majority of the cell populations of the anterior and posterior lobe as well as in the area localized between the anterior and posterior lobe, and arbitrary defined as “intermediate zone”. This zone, characterized by the presence of nerve fibers included the residual pars intermedia represented by the colloid-filled cysts lined by the remnant melanotroph cells strongly expressing D2 receptors, and clusters of corticotroph cells, belonging to the anterior lobe but localized within the cysts and adjacent to the posterior lobe, variably expressing D2 receptors. D2 dopamine receptor is expressed in the majority of the cell populations of the human normal pituitary gland, and particularly, in the different corticotroph cell populations localized in the anterior lobe and the intermediate zone of the pituitary gland.

Additional Metadata
Keywords ACTH, Corticotroph cells, Cushing’s syndrome, Dopamine agonists, Dopamine receptors, Pituitary
Persistent URL dx.doi.org/10.1007/s12020-016-1107-2, hdl.handle.net/1765/93762
Journal Endocrine : International Journal of Basic and Clinical Endocrinology
Citation
Pivonello, R, Waaijers, M, Kros, J.M, Pivonello, C, de Angelis, C, Cozzolino, A. (Alessia), … Hofland, L.J. (2017). Dopamine D2 receptor expression in the corticotroph cells of the human normal pituitary gland. Endocrine : International Journal of Basic and Clinical Endocrinology, 57(2), 314–325. doi:10.1007/s12020-016-1107-2